Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20080901001165N54Phase 3Completed
Phase 3, randomised, double-blind trial in Pulmonary disease due to chemical warfare agents and Pulmonary lesion comparing N-acetylcysteine + vitamin B6 with N-acetylcysteine + placebo (2 arms). Primary endpoint: Antioxidant effect. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20080901001165N54.